NCT02211482View on ClinicalTrials.gov

Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2017

Conditions

HIV-1 Infection

Interventions

DRUG

dolutegravir, lamivudine

single arm

Trial Locations (1)

C1202ABB

Fundacion Huesped, CABA

Sponsors

Collaborators (1)

ViiV Healthcare

All Listed Sponsors

collaborator

ViiV Healthcare

INDUSTRY

lead

Fundación Huésped

OTHER